Changes in plasma lipids after a non-lethal dose of cycloheximide in rats

Hum Exp Toxicol. 2003 May;22(5):245-8. doi: 10.1191/0960327103ht355oa.

Abstract

This paper describes a study of the effect of a single intraperitoneal non-lethal dose of cycloheximide (CHM; 2.0 mg/kg body weight) on the concentration of plasma lipids and lipoproteins in male rats killed one, two, three, four and nine days after receiving the dose. The concentration of triglycerides, total cholesterol, high-density lipoproteins (HDL)-cholesterol and low-density lipoproteins (LDL)-cholesterol was measured in treated and control animals. The effect of CHM on the concentration of triglycerides, total cholesterol, HDL-cholesterol, and LDL-cholesterol was visible in rat plasma throughout the study. Total cholesterol and HDL-cholesterol concentrations showed the same pattern of changes, probably due to the reversible inhibition of apolipoprotein apo A-I synthesis by CHM. The concentration of triglycerides decreased after a lag period of three days when the reserves of apolipoprotein apo B, the main apolipoprotein of very low-density lipoproteins (VLDL)-cholesterols produced in the liver, were consumed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cycloheximide / administration & dosage*
  • Cycloheximide / pharmacology
  • Dose-Response Relationship, Drug
  • Injections, Intraperitoneal
  • Lipoproteins / antagonists & inhibitors
  • Lipoproteins / blood*
  • Lipoproteins / drug effects*
  • Male
  • Rats
  • Rats, Wistar
  • Time Factors

Substances

  • Lipoproteins
  • Cycloheximide